Literature DB >> 29845918

Ethical Reflections on the Equity of the Current Basic Health Insurance System Reform in China: A Case Study in Hunan Province.

Junxiang Liu, Jingzi Xu, Tianyu Zhang, Yonghui Ma.   

Abstract

China's current basic health insurance reform aims at promoting equity in the economic accessibility of health services for all citizens, to better ensure healthcare justice. Therefore, it is important to assess equity not only from a socioeconomic perspective but also from an ethical angle. This article investigates the basic health insurance system of Hunan Province in China by focusing on insurance types as well as their classification standards, mechanisms, and utilization according to local policy documents and data. This study demonstrates the reforming achievements and the inequity of institutional design according to two interrelated dimensions: equal opportunity of access to healthcare insurance and reducing inequality in insurance benefits. The article concludes that to achieve opportunity equity and outcome fairness, the reform should focus on designing the system to promote equity with respect to procedures and rules and to be more attentive to the interests of vulnerable groups and especially to rural residents.

Keywords:  basic health insurance; equal opportunity; equity; outcome fairness; procedural justice; universality

Mesh:

Year:  2018        PMID: 29845918     DOI: 10.1017/S0963180117000834

Source DB:  PubMed          Journal:  Camb Q Healthc Ethics        ISSN: 0963-1801            Impact factor:   1.284


  2 in total

1.  Challenges in the ethics review process of clinical scientific research projects in China.

Authors:  Zhu-Heng Wang; Guan-Hua Zhou; Li-Ping Sun; Jun Gang
Journal:  J Int Med Res       Date:  2019-09-20       Impact factor: 1.671

2.  Outpatients' Satisfaction in the Context of 10 Years of Health-Care Reform: A Cross-Sectional Study of Tertiary Hospitals in Shiyan, China.

Authors:  Li Ke; Jingshu Chen; Jia Jia; Pan Ke; Xueqin Chen; Zongfu Mao; Bing Liu
Journal:  Patient Prefer Adherence       Date:  2020-01-29       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.